Market research reports on: DNA, RNA, proteomics, genomics, genetics, cancer, cell, protein, sequencing, biomarkers, peptides, in vitro diagnostics, molecular and others.
Let's ConnectGlobal Market for Stem Cells
The global stem cell market reached $32.1 billion in 2022 and should reach $65.6 billion by 2027, with a compound annual growth rate (CAGR) of 15.3% during the forecast period of 2022-2027.
Glycobiology: Global Markets for Diagnostics and Therapeutics
The global glycobiology market should reach $5.3 billion by 2027 from $3.2 billion in 2022 at a compound annual growth rate (CAGR) of 11.1% for the forecast period of 2022 to 2027.
Global Spatial Genomics and Transcriptomics Market
The global market for spatial genomics and transcriptomics is estimated to increase from $1.5 billion in 2022 to reach $2.5 billion by 2027, at a compound annual growth rate (CAGR) of 10.8% from 2022 through 2027.
Sample Preparation in Genomics, Proteomics, and Epigenomics: Glob...
The global sample preparation in genomics, proteomics, and epigenomics market should reach $7.4 billion by 2027 from $5.4 billion in 2022 at a compound annual growth rate (CAGR) of 6.4% for the forecast period of 2022 to 2027.
High-Performance Liquid Chromatography (HPLC): Global Market
The global high-performance liquid chromatography (HPLC) market should reach $5.7 billion by 2027 from $4.5 billion in 2022 at a compound annual growth rate (CAGR) of 5.2% for the forecast period of 2022 to 2027.
Global Markets for Microbiology Technology, Equipment and Consuma...
The global microbiological technology, equipment and consumables market should reach $8.5 billion by 2027 from $5.6 billion in 2022 at a compound annual growth rate (CAGR) of 8.9% for the forecast period of 2022 to 2027.
Biologics Development and Manufacturing Testing: Technologies and...
The global market for biologics safety testing is estimated to increase from $7.4 billion in 2022 to reach $18.2 billion by 2027, at a compound annual growth rate (CAGR) of 19.9% from 2022 through 2027.
Immunoassays: Technologies and Global Markets
The global immunoassay tests market reached $30.6 billion in 2022 and should reach $39.8 billion by 2027, with a compound annual growth rate (CAGR) of 5.4% during the forecast period of 2022-2027.
DNA Data Storage: Global Markets and Technologies
The global DNA data storage market should reach $1.5 billion by 2027 from $105.5 million in 2022 at a compound annual growth rate (CAGR) of 69.8% for the forecast period of 2022 to 2027.
Cardiac Biomarkers: Technologies and Global Markets
The global market for cardiac biomarkers is estimated to increase from $13.4 billion in 2022 to reach $23.8 billion by 2027, at a compound annual growth rate (CAGR) of 12.2% from 2022 through 2027.
Microbiome Therapeutics: Global Markets
The global market for microbiome therapeutics is estimated to increase from $164.8 million in 2022 to reach $1.5 billion by 2027, at a compound annual growth rate (CAGR) of 54.8% from 2022 through 2027.
Bioprinting: Technologies and Global Markets
The global bioprinting technologies market should reach $5.0 billion by 2027 from $2.4 billion in 2022 at a compound annual growth rate (CAGR) of 16.2% for the forecast period of 2022 to 2027.
Pyrogen Testing: Global Market Outlook
The goal is to provide an up-to-date analysis of the global pyrogen testing market and future opportunities in the market. The report provides an overview of the global pyrogen testing market and analyzes market trends. It also highlights major trends and challenges that affect the market and the vendor landscape. The scope of the study includes market drivers and restraints, the competitive landscape, and current and emerging technologies. And revenue forecasts for the period (2022-2027) are made for test type, products and services, end user and geography in the study.
Renal Biomarkers: Technologies and Global Markets
The global market for renal biomarkers is estimated to increase from $1.2 billion in 2022 to reach $1.7 billion by 2027, at a compound annual growth rate (CAGR) of 7.6% from 2022 through 2027.
Flow Cytometry: Products, Technologies and Global Markets
The global market for flow cytometry is estimated to increase from $5.2 billion in 2022 to reach $7.6 billion by 2027, at a compound annual growth rate (CAGR) of 8.0% from 2022 through 2027.
Human Microchipping: Global Market Outlook
Microchips can provide a distinctive identification when implanted in humans and animals. The goal is to provide an up-to-date analysis of the human microchipping market and future opportunities in the market. It presents a thorough and up-to-date global assessment of the market and business of the human microchipping. This will help industry participants, suppliers, government bodies, associations, and customers make the informed decisions needed to compete and succeed in the marketplace. The main objective of the study is to provides an overview of the technological, demographic and economic developments that may have a long-term impact on the market and to present a comprehensive analysis of the current market and the future direction of the market.
Proteomics: Technologies and Global Markets
The global proteomics market should reach $55.1 billion by 2027 from $27.1 billion in 2022 at a compound annual growth rate (CAGR) of 15.3% for the forecast period of 2022 to 2027.
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for cell and gene therapy tools and reagents is estimated to grow from $8.3 billion in 2022 to $13.7 billion in 2027, with a compound annual growth rate (CAGR) of 10.6% for the period of 2022-2027.
Global Microarray Market
The global market for microarrays is estimated to grow from $4.0 billion in 2022 to $5.7 billion in 2027, with a compound annual growth rate (CAGR) of 7.6% for the period of 2022-2027.
Global Primary Cells Market
The global primary cells market should reach $1.9 billion by 2027 from $1.3 billion in 2022 at a compound annual growth rate (CAGR) of 9.0% for the forecast period of 2022 to 2027.
Global Bio Decontamination Market
The global bio decontamination market should reach $166.9 million by 2022 and more than $232 million by 2027, with a compound annual growth rate (CAGR) of 6.8% during the forecast period of 2022-2027.
Human Recombinant DNA: Global Markets
The global human recombinant DNA market should reach $348.7 billion by 2022 and more than $496.9 billion by 2027, with a compound annual growth rate (CAGR) of 7.3% during the forecast period of 2022-2027.
Cell-Based Assays: Technologies and Global Markets
The global cell-based assays market should reach $47.3 billion by 2027 from $29.2 billion in 2022 at a compound annual growth rate (CAGR) of 10.2% for the forecast period of 2022 to 2027.
In Vitro Diagnostics (IVD) Quality Controls: Global Market
The global in vitro diagnostic (IVD) quality controls market should reach $1.6 billion by 2027 from $1.2 billion in 2022 at a compound annual growth rate (CAGR) of 5.5% for the forecast period of 2022 to 2027.
Sterile Filtration Market for Lifescience
The global sterile filtration market should reach $5.3 billion by 2027 from $3.0 billion in 2022 at a compound annual growth rate (CAGR) of 12.0% for the forecast period of 2022 to 2027.
Choose your License
Global Markets for Research Antibodies
- An overview of the global market landscape related to the research antibodies
- In-depth analysis of global market trends, featuring historical revenue data for 2020-2022, estimated figures for 2023, as well as forecasts for 2028. This analysis includes projections of Compound Annual Growth Rates (CAGRs) spanning through 2028
- Evaluation of the current market size and revenue growth prospects specific to research antibodies, accompanied by a comprehensive market share analysis categorized by product, clonality, application, major reactivities, host species, end-user, and geographical region
- Discussion on the factors affecting the companies’ market shares, the current strategies of antibody companies, the effect of research funding, and the third-party quality evaluation systems of research antibodies
- Description of antibody technologies, emerging antibody generation technologies and identification of market drivers, restraints and other forces impacting the global market
- Discussion on technological trends in antibody production and application, and information on antibody-based drug discovery and development process
- Impact analysis of COVID-19 on entire pharma industry and discussion on how COVID-19 is related to pharmaceutical industry’s growth slow-down and results in delayed approvals for non-COVID-19-related pharmaceutical/biotech products
- Coverage of new discoveries in biological sciences, rapid technological developments in the IVD industry, new antibody technologies and antibody types, and assessment of antibody-based drug discovery and development
- Discussion on advantages and disadvantages of antibody discovery technologies with examples of antibody production, and information on REpAb technology
- Coverage of FDA and international regulations, details of recent regulatory reforms and list of antibody therapeutics granted in 2018 and insights into government initiatives and funding in emerging markets
- Examination of environmental, social, and corporate governance (ESG) developments, a relevant patent analysis; and merger and acquisitions (M&A), venture fundings, and emerging technologies in the global research antibodies
- Detailed profiles of leading market participants, providing a descriptive overview of their respective businesses
mRNA: Therapeutics and Global Markets
- An overview of the global market landscape related to the mRNA therapeutics
- In-depth analysis of global market trends, featuring historical revenue data for 2021, 2022, estimated figures for 2023, as well as forecasts for 2028. This analysis includes projections of Compound Annual Growth Rates (CAGRs) spanning through 2028
- Evaluation of the current market size and revenue growth prospects specific to mRNA therapeutics, accompanied by a comprehensive market share analysis categorized by therapeutic types, and geographical region
- Coverage of the major developments, pandemic threats, therapeutic developments, and technological developments of the mRNA therapeutics market
- Discussion on significant advantages of mRNA over protein or DNA-based delivery systems and description of demographic and economic trends, and outlook of the mRNA therapeutics market
- Evaluation of current market size and forecast, and information on prophylactic vaccines, vaccine discovery and development, and R&D activities
- Analysis of the various innovative therapeutics as well as new promising vaccines intended for the prevention and treatment of various chronic and infectious diseases
- Assessment of regulatory structure, pricing and reimbursement scenario, and pipeline analysis of the new molecules & therapeutics
- Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies
- Detailed profiles of leading market participants, providing a descriptive overview of their respective businesses
Induced Pluripotent Stem Cells: Global Markets
- An overview of the global market landscape related to the induced pluripotent stem cells
- In-depth analysis of global market trends, featuring historical revenue data for 2021, 2022, estimated figures for 2023, as well as forecasts for 2028. This analysis includes projections of Compound Annual Growth Rates (CAGRs) spanning through 2028
- Evaluation of the current market size and revenue growth prospects specific to induced pluripotent stem cells, accompanied by a comprehensive market share analysis categorized by application, method, type, species, products, function, clinical use, and geographical region
- Analysis of the market's dynamics, including growth drivers, inhibitors, and opportunities, and insights into the regulatory environments impacting the market
- Assessment of recent or ongoing research and development activities in the iPSCs segment, highlights of the new developments and the recent pipeline products
- Information on the latest research activities, emerging technologies, and clinical trials
- Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies
- Comprehensive company profiles of major players of the industry
Next-generation Sequencing: Emerging Clinical Applications and Global Markets
- An overview of the global market landscape related to the emerging clinical applications of the next-generation sequencing
- In-depth analysis of global market trends, featuring historical revenue data for 2020-2022, estimated figures for 2023, as well as forecasts for 2028. This analysis includes projections of Compound Annual Growth Rates (CAGRs) spanning through 2028
- Evaluation of the current market size and revenue growth prospects specific to next-generation sequencing, accompanied by a comprehensive market share analysis categorized by disease indication, test complexity, test purpose, application, and geographical region
- Discussion on market opportunities for clinical NGS products, clinical applications, industry structure, regulatory scenario, and penetration of NGS-based diagnostics and technologies within the industry
- Coverage of genome mapping programs, discussion on technological advancements and innovations in sequencing platforms, and information on Ion Torrent Genexus System launched by Thermo Fisher Scientific and Magnis NGS Prep System launched by Agilent Technologies, Inc.
- Description of NGS-oriented tests such as non-invasive prenatal testing (NIPT), and pre-implantation genetic testing (PGT) and discussion on their advantages
- Market share analysis of the key companies of the industry and coverage of their proprietary technologies, strategic alliances, and other key market strategies and a relevant patent analysis
- Comprehensive company profiles of the leading players of the industry
Polymerase Chain Reaction (PCR) Technologies and Global Markets
- An overview and up-to-date analysis of the global markets for the polymerase chain reaction (PCR) technologies
- Analyses of the global market trends, with historical market revenue data (sales figures) from 2021 to 2022, estimates for 2023, forecasts for 2024, and projections of compound annual growth rates (CAGRs) through 2028
- Estimate of the actual market size and revenue forecast for the PCR markets in USD millions, and corresponding market share analysis based on product, technology, application, and region
- In-depth information (facts and figures) pertaining to the major market dynamics, R&D efforts, current status on MedTech, upcoming technologies, future demand in clinical diagnostics, and regulatory scenarios; and the impacts of COVID-19 pandemic on the worldwide market
- Identification of the companies that are best positioned to meet the surging demand for innovations in PCR technology, owing to or in conjunction with their proprietary technologies, strategic alliances, and other competitive advantages
- Discussion of sustainability trends and factors in emerging materials in the aerospace industry, with emphasis on consumer attitudes, ESG score analysis, future of ESG, and the ESG practices followed
- An overview of the major vendors in the global PCR market along with an analysis of the structure of the industry, including company market shares and recent mergers and acquisitions (M&A) activity
- Review of both new and existing patents on PCR technologies and their applications in molecular diagnosis of infectious diseases
- Profiles of the leading global players
3D Cell Cultures: Technologies and Global Markets
- An overview of the global market landscape related to the 3D cell cultures technologies
- In-depth analysis of global market trends, featuring historical revenue data for 2020-2022, estimated figures for 2023, as well as forecasts for 2028. This analysis includes projections of Compound Annual Growth Rates (CAGRs) spanning through 2028
- Evaluation of the current market size and revenue growth prospects specific to 3D cell cultures technologies, accompanied by a comprehensive market share analysis categorized by type, end user, and geographical region
- Information on analytical systems used in tissue and cell culture, cellomics, and human cancer model initiative (HCMI)
- Details about assay development for mesenchymal stem cells, In Vitro testing of adventitious agents and description of assays and assay kits
- A look at the main classes of models for researching cancer and other diseases, benefits of 3D models to cancer research and description of 3D engineered scaffolds
- Analysis of the market's dynamics, specifically growth drivers, restraints, and opportunities and discussion on the impact of COVID-19 on the world of cell culture
- Insights into U.S. regulatory status of bioprinted products; basic guidance for the regulation of biologics, regenerative medicine and xenotransplants
- Relevant patent analysis, including recent activity and a list of key patents
- Detailed profiles of leading market participants, providing a descriptive overview of their respective businesses
Top Ten Suppliers of Synthetic Biology Technology
- An overview of the global market landscape related to the top ten suppliers of synthetic biology technology
- In-depth analysis of global market trends, featuring historical revenue data for 2022, estimated figures for 2023, as well as forecasts for 2028. This analysis includes projections of Compound Annual Growth Rates (CAGRs) spanning through 2028
- Evaluation of the current market size and revenue growth prospects specific to top ten suppliers of synthetic biology technology, accompanied by a comprehensive market share analysis categorized by product type, and geographical region
- Coverage of evolving technologies and highlights of the current and future market potential and a detailed analysis of the regulatory framework and reimbursement scenarios
- Review of patents, product pipeline, ESG trends, and emerging technologies related to synthetic biology
- Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies
- Detailed profiles of leading market participants, providing a descriptive overview of their respective businesses
Life Science Tools and Reagents: Global Markets
- Overview and an up-to-date analysis of the global markets for life sciences tools and reagents
- Analyses of the global market trends, with historical market revenue data (sales figures) from 2020 to 2022, estimates for 2023, forecasts for 2024, and projections of compound annual growth rates (CAGRs) through 2028
- Estimate of the market size and revenue forecast for the life science tools and diagnostics market, and corresponding market share analysis based on product type, end user application, and region
- Highlights of the current and future market potential of life science tools and diagnostics, along with a detailed analysis of the competitive environment, regulatory scenario, and technological advances
- In-depth information (facts and figures) pertaining to the major market dynamics, opportunities and deterrents, emerging technologies, future prospects, and the impacts of macroeconomic variables
- Assessment of existing products and identification of new potential markets for novel products and assay development
- Discussion on how scientific trends, government policies, and the economy in general affect life sciences tools and diagnostics market and how this industry is different from the pharmaceutical and drug discovery industry
- Overview of the sustainability trends and factors in the life science tools and diagnostics market, with emphasis on consumer attitudes, ESG score analysis, future of ESG, and the ESG practices followed
- An analysis of the key patent grants and recent patent publications
- Identification of the major vendors along with an analysis of the competitive landscape, including company market shares, recent M&A activities, and venture funding outlook
- Company profiles of the leading market players
Western Blotting: Global Markets
- An overview of the global market landscape related to the western blotting
- In-depth analysis of global market trends, featuring historical revenue data for 2020-2022, estimated figures for 2023, as well as forecasts for 2028. This analysis includes projections of Compound Annual Growth Rates (CAGRs) spanning through 2028
- Evaluation of the current market size and revenue growth prospects specific to western blotting, accompanied by a comprehensive market share analysis categorized by product, application, end-user, and geographical region
- Description of concepts like gel electrophoresis and antibody probing, and processes like tissue preparation, protein transfer, blocking and antibody interactions
- Discussion on major application areas of western blotting technique such as disease diagnostics, agriculture, biomedical & biochemical research
- Assessment of processes like protein separations and extraction of target proteins, and introduction of new and innovative imaging platforms such as fluorescent, multiplex, and chemiluminescent western blotting techniques and their protocol
- Coverage of emerging technologies in western blotting market, recent developments, future opportunities, patent review, product pipeline, and ESG trends
- Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies
- Detailed profiles of leading market participants, providing a descriptive overview of their respective businesses
Biologic Therapeutic Drugs: Technologies and Global Markets
- Overview and an up-to-date analysis of the global markets for biologic therapeutic drugs
- Analyses of the global market trends, with historical market revenue data (sales figures) from 2021 to 2022, estimates for 2023, forecasts for 2024, and projections of compound annual growth rates (CAGRs) through 2028
- Estimate of the actual market size and revenue forecast for the global biologics market, and its corresponding market share analysis based on the product type, therapeutic area, and region
- Discussion of the major factors influencing the growth of this market with respect to opportunities and challenges, upcoming technologies, future demand, regulations, and contributions to the overall market
- Overview of the sustainability trends and factors in the market for biologic therapeutic drugs, with emphasis on consumer attitudes, ESG score analysis, future of ESG, case study, and the ESG practices followed
- Identification of the biopharmaceutical companies that are considered as leaders in their field, as well as technological means these companies are using to exploit their markets and dominate the market in their fields
- Evaluation of the ongoing clinical trials and R&D activities estimating current and future demand for biologics production
- A look at the key marketed drugs and recent approvals, sales statistics and past performance of the top selling biologics, and insight into their patent expiries
- Review of the emerging new technologies and interesting patents on the biologic therapeutic drugs
- An overview of the major vendors along with an analysis of the industry structure, including company market shares, recent mergers and acquisitions, and venture fundings outlook
- Profiles of the leading market players